Home › Squamous Cell Carcinoma ng Ulo at Leeg › Missouri › St. Louis
Pag-aaral pangklinika para sa Squamous Cell Carcinoma ng Ulo at Leeg sa St. Louis, MO
Isang pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa St. Louis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Nagre-recruitPhase 3
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi ang layo
- at 1 pa
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine in St. Louis, St Louis
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Nagre-recruitPhase 2/3
- Site #0114, St Louis
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Nagre-recruitPhase 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- at 4 pa
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Nagre-recruitPhase 3
- Washington University School Of Medicine, St Louis
- Cancer Care Specialists of Central Illinois, O'Fallon · 16 mi ang layo
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Nagre-recruitPhase 1/2
- Washington University School Of Medicine, St Louis
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- at 4 pa
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 mi ang layo
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Nagre-recruitPhase 1/2
- Washington University, St Louis
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Nagre-recruitPhase 1/2
- Washington Univ. School of Medicine, St Louis
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Nagre-recruitPhase 2
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- at 4 pa
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Washington University, St Louis
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Nagre-recruitPhase 1
- Washington University, St Louis
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Nagre-recruitObservasyonal na pag-aaral
- Washington University in St. Louis, St Louis
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Nagre-recruitPhase 1
- Normunity Investigational Site, St Louis
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Nagre-recruitPhase 2/3
- SSM Health Saint Louis University Hospital, St Louis
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Nagre-recruitPhase 3
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi ang layo
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 mi ang layo
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Washington University School of Medicine at St Louis, St Louis
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Nagre-recruitPhase 2
- Washington University School of Medicine, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Washington University, St Louis
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 3
- GSK Investigational Site, St Louis
5-Fluorouracil Response and Optimization STudy (The FROST Trial)
Nagre-recruitPhase 2
- Washington University School of Medicine, St Louis
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 3
- Siteman Cancer Center - Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Washington University, St Louis
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Nagre-recruit
- Washington University in St. Louis, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Washington University, St Louis
Validity of Viome's Oral/throat Cancer Test
Nagre-recruitObservasyonal na pag-aaral
- Missouri School of Dentistry & Oral Health, St Louis
Pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg sa ibang lungsod
- Houston, TX47 pag-aaral
- Los Angeles, CA42 pag-aaral
- Boston, MA40 pag-aaral
- New York City, NY39 pag-aaral
- Nashville, TN39 pag-aaral
- Arlington, VA26 pag-aaral
- Philadelphia, PA26 pag-aaral
- Chicago, IL26 pag-aaral
- Atlanta, GA24 pag-aaral
- San Antonio, TX22 pag-aaral
- New Haven, CT22 pag-aaral
- Pittsburgh, PA22 pag-aaral
Iba pang pag-aaral sa St. Louis
- Non-Small Cell Lung Cancer73 pag-aaral
- Kanser sa Suso64 pag-aaral
- Metastatic Cancer54 pag-aaral
- Colorectal Cancer50 pag-aaral
- Kanser (lahat ng uri)46 pag-aaral
- Kanser sa Prostate46 pag-aaral
- Kanser sa Baga39 pag-aaral
- Kanser sa Ovary38 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Kanser ng Endometrium29 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
- Obesity25 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.